After a banner year, Samsung will charge forward with ‘super plant’ plans, and look to expand abroad

Samsung Biologics’ future plans involve a lot of big, important, expensive buildings. And now, the company revealed in its Q4 earnings meeting, several of those expensive buildings, part of a massive “super plant,” will feature a heavy emphasis on mRNA, as the success and demand for Covid-19 vaccines continues to...

Click to view original post